RitaKKramerMD
Oncology • Charleston, SCBreast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology
Physician
Dr. Kramer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 1992 - 1993- University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
- University of Kentucky College of MedicineResidency, Internal Medicine, 1984 - 1988
University of Kentucky College of MedicineClass of 1984
Certifications & Licensure
SC State Medical License 2009 - 2023
KY State Medical License 1985 - 2021
TX State Medical License 2002 - 2016
TN State Medical License 1990 - 1992
MD State Medical License 1989 - 1991- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 4 citationsBMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E. Bauza, Victoria J. Findlay, David P. Turner, Latecia M. Abraham
Advances in Cancer Research. 2020-01-01 - 33 citationsAdvanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interven...Katherine R. Walter, Marvella E. Ford, Mathew J. Gregoski, Rita Kramer, Kendrea D. Knight
Breast Cancer Research and Treatment. 2019-02-01 - 2 citationsAlcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship.Vivian J. Bea, Joan E. Cunningham, Anthony J. Alberg, Dana R. Burshell, Colleen E. Bauza
Frontiers in Oncology. 2018-09-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
